BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Telix Pharmaceuticals Appointed Dr. Bernard Lambert as President of Telix Pharmaceuticals (US) Inc.

  Dr. Lambert was previously Vice President, CMC and Radiopharmaceutical Development at Zevacor Molecular and IBA Molecular.

  December 4, 2017

   · 

  2 min read
• Dr. Adam Lewis to Adopt EOI’s FLXfit Articulated and Expandable Cages as His Treatment of Choice for MIS TLIF

  Dr. Lewis is a prominent neurosurgeon and founder of the Jackson Neurosurgery Clinic in Jackson MS.

  December 4, 2017

   · 

  2 min read
• Drug Development

  BioPharmX Demonstrates Topical Minocycline Gel May Exhibit Relevant Antimicrobial and Anti-Inflammatory Properties for the Treatment of Acne at ASCB 2017

  Study findings show that minocycline has anti-inflammatory activities in in vitro and animal models.

  December 4, 2017

   · 

  3 min read
• Drug Development

  Morphotek Announces Initiation of Phase I Study of Next-Generation Farletuzumab Antibody-Drug Conjugate MORAb-202 in Solid Tumors With Folate Receptor Alpha Expression

  The Phase I trial, which is being conducted in Japan and referred to as MORAb-202-J081-101, is a first-in-human, dose-escalation study evaluating the safety and preliminary efficacy of MORAb-202 in patients with solid tumors that express FRA.

  December 4, 2017

   · 

  8 min read
• Drug Development

  Foresee Pharma Announces Results From Phase I Clinical Studies

  The objectives of these studies were to evaluate the safety, tolerability, and pharmacokinetics of oral ascending doses of FP-025 in healthy subjects.

  December 4, 2017

   · 

  3 min read
• Policy

  Breckenridge Pharmaceutical Announces Final Approval of its ANDA Megestrol Acetate Oral Suspension (Megace ES)

  The company will launch immediately.

  December 4, 2017

   · 

  1 min read
• AC Immune Shares Insights From Key Opinion Leader Meeting on Tau as a Therapeutic and Diagnostic Target in Alzheimer’s and Other Neurodegenerative Diseases

  The meeting featured presentations by KOLs Khalid Iqbal, PhD (New York State Institute for Basic Research in Developmental Disabilities) and Michael Rafii, MD, PhD (UC San Diego and USC).

  December 4, 2017

   · 

  5 min read
• Cobra Biologics Wins ‘Company of the Year’ and ‘Technical Services’ Awards in Double Success at 2017 Bionow Awards

  Cobra Biologics is very proud to have been named as Company of the Year as well as being presented with the Technical Service Award in this year’s Bionow Awards.

  December 4, 2017

   · 

  1 min read
• Almac Discovery Publishes USP7 Inhibitors From UbiPlex Platform

  Almac Discovery has today published its findings on the discovery and characterisation of highly potent, selective and reversible inhibitors of USP7 in the journal Nature Chemical Biology.

  December 4, 2017

   · 

  1 min read
• Business

  curasan Signs New Cooperation With Implantcast for the DACH-Region

  curasan AG has signed an exclusive distribution agreement with Implantcast GmbH, Buxtehude, Germany.

  December 4, 2017

   · 

  4 min read